|
Rolitetracycline
|
D02.455.426.559.847.562.900.720 |
|
|
Binding, Competitive
|
G02.111.084 |
|
|
Fanconi Anemia Complementation Group A Protein
|
D12.776.313.500 |
|
|
Atrial Natriuretic Factor
|
D12.644.548.585.500 |
|
|
Natriuretic Peptides
|
D12.644.548.585 |
|
|
Base Composition
|
G02.111.080 |
|
|
Megasphaera
|
B03.440.425.400.500 |
|
|
Lidocaine, Prilocaine Drug Combination
|
D26.310.454 |
|
|
Olfactory Tubercle
|
A08.186.211.200.885.287.500.620.656 |
|
|
Purchasing, Hospital
|
N02.278.216.500.968.679 |
|
|
Microbial Sensitivity Tests
|
E05.337.550.400 |
|
|
Drug Evaluation, Preclinical
|
E05.337.550 |
|
|
Matrix Metalloproteinase 20
|
D12.776.467.836.800 |
|
|
Autotrophic Processes
|
G02.111.071 |
|
|
Heart Disease Risk Factors
|
D000082742 |
[Aspects of personal behavior or lifestyle, environmental exposure, inherited conditions and characteristics, which are determined to be associated with HEART DISEASES.
] |
|
Neon
|
D01.362.641.592 |
|
|
Amyloid Neuropathies, Familial
|
C18.452.845.500.050.050 |
|
|
Amyloid Neuropathies
|
C18.452.845.500.050 |
|
|
Water Intoxication
|
C18.452.950.932 |
|
|
Water-Electrolyte Imbalance
|
C18.452.950 |
|
